Koa Wealth Management LLC Sells 861 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Koa Wealth Management LLC reduced its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,223 shares of the exchange traded fund’s stock after selling 861 shares during the quarter. Koa Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $911,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of XBI. Healthcare of Ontario Pension Plan Trust Fund boosted its position in SPDR S&P Biotech ETF by 30.3% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after acquiring an additional 730,000 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in SPDR S&P Biotech ETF by 1.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after purchasing an additional 18,202 shares during the period. Jane Street Group LLC increased its holdings in SPDR S&P Biotech ETF by 68.7% in the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares in the last quarter. Bessemer Group Inc. lifted its stake in SPDR S&P Biotech ETF by 1.7% in the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock valued at $87,572,000 after buying an additional 15,794 shares during the period. Finally, Employees Retirement System of Texas boosted its holdings in shares of SPDR S&P Biotech ETF by 40.8% during the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after buying an additional 174,857 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 5.2 %

Shares of XBI stock opened at $91.88 on Friday. SPDR S&P Biotech ETF has a 52 week low of $69.32 and a 52 week high of $105.47. The firm has a 50 day moving average of $98.95 and a 200-day moving average of $96.03. The company has a market cap of $7.00 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.